Logo image of MTRX

MATRIX SERVICE CO (MTRX) Stock Fundamental Analysis

NASDAQ:MTRX - Nasdaq - US5768531056 - Common Stock - Currency: USD

12.71  +0.04 (+0.32%)

After market: 12.71 0 (0%)

Fundamental Rating

3

MTRX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 51 industry peers in the Construction & Engineering industry. The financial health of MTRX is average, but there are quite some concerns on its profitability. MTRX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MTRX had negative earnings in the past year.
In the past year MTRX had a positive cash flow from operations.
MTRX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTRX reported negative operating cash flow in multiple years.
MTRX Yearly Net Income VS EBIT VS OCF VS FCFMTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.68%, MTRX is doing worse than 74.51% of the companies in the same industry.
With a Return On Equity value of -14.97%, MTRX is not doing good in the industry: 74.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.68%
ROE -14.97%
ROIC N/A
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
MTRX Yearly ROA, ROE, ROICMTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Gross Margin value of 5.93%, MTRX is not doing good in the industry: 74.51% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of MTRX has declined.
MTRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
MTRX Yearly Profit, Operating, Gross MarginsMTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

4

2. Health

2.1 Basic Checks

MTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTRX has more shares outstanding
Compared to 5 years ago, MTRX has more shares outstanding
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MTRX Yearly Shares OutstandingMTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MTRX Yearly Total Debt VS Total AssetsMTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MTRX has an Altman-Z score of 1.56. This is a bad value and indicates that MTRX is not financially healthy and even has some risk of bankruptcy.
MTRX has a worse Altman-Z score (1.56) than 62.75% of its industry peers.
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.56
ROIC/WACCN/A
WACC10.2%
MTRX Yearly LT Debt VS Equity VS FCFMTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.00 indicates that MTRX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.00, MTRX is doing worse than 70.59% of the companies in the same industry.
MTRX has a Quick Ratio of 1.00. This is a bad value and indicates that MTRX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MTRX (0.99) is worse than 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.99
MTRX Yearly Current Assets VS Current LiabilitesMTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

MTRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.30%, which is quite impressive.
MTRX shows a decrease in Revenue. In the last year, the revenue decreased by -0.30%.
Measured over the past years, MTRX shows a very negative growth in Revenue. The Revenue has been decreasing by -12.46% on average per year.
EPS 1Y (TTM)23.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.36%
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%20.57%

3.2 Future

The Earnings Per Share is expected to grow by 44.31% on average over the next years. This is a very strong growth
MTRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.09% yearly.
EPS Next Y38.42%
EPS Next 2Y61.29%
EPS Next 3Y44.31%
EPS Next 5YN/A
Revenue Next Year5.89%
Revenue Next 2Y12.92%
Revenue Next 3Y11.09%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MTRX Yearly Revenue VS EstimatesMTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
MTRX Yearly EPS VS EstimatesMTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 19.94 indicates a rather expensive valuation of MTRX.
Based on the Price/Forward Earnings ratio, MTRX is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.19. MTRX is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 19.94
MTRX Price Earnings VS Forward Price EarningsMTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than MTRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3
EV/EBITDA N/A
MTRX Per share dataMTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTRX's earnings are expected to grow with 44.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.29%
EPS Next 3Y44.31%

More info and screens

0

5. Dividend

5.1 Amount

MTRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MATRIX SERVICE CO

NASDAQ:MTRX (6/18/2025, 8:10:18 PM)

After market: 12.71 0 (0%)

12.71

+0.04 (+0.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)09-08 2025-09-08/amc
Inst Owners88.15%
Inst Owner Change3.69%
Ins Owners4%
Ins Owner Change0.02%
Market Cap350.92M
Analysts82.86
Price Target17.34 (36.43%)
Short Float %2.34%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.15%
Min EPS beat(2)-132.96%
Max EPS beat(2)12.66%
EPS beat(4)2
Avg EPS beat(4)-21.77%
Min EPS beat(4)-132.96%
Max EPS beat(4)34.64%
EPS beat(8)3
Avg EPS beat(8)-68.85%
EPS beat(12)4
Avg EPS beat(12)-89.55%
EPS beat(16)4
Avg EPS beat(16)-181.58%
Revenue beat(2)0
Avg Revenue beat(2)-4.82%
Min Revenue beat(2)-8.75%
Max Revenue beat(2)-0.89%
Revenue beat(4)0
Avg Revenue beat(4)-5.57%
Min Revenue beat(4)-8.75%
Max Revenue beat(4)-0.89%
Revenue beat(8)0
Avg Revenue beat(8)-7.24%
Revenue beat(12)2
Avg Revenue beat(12)-5.13%
Revenue beat(16)3
Avg Revenue beat(16)-4.79%
PT rev (1m)-5.56%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-95.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-144.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.94
P/S 0.47
P/FCF 3
P/OCF 2.84
P/B 2.33
P/tB 2.9
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)0.64
Fwd EY5.02%
FCF(TTM)4.24
FCFY33.35%
OCF(TTM)4.48
OCFY35.27%
SpS26.89
BVpS5.46
TBVpS4.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.68%
ROE -14.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.93%
FCFM 15.76%
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 65.83%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.99
Altman-Z 1.56
F-Score6
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)50.41%
Cap/Depr(5y)54.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.36%
EPS Next Y38.42%
EPS Next 2Y61.29%
EPS Next 3Y44.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%20.57%
Revenue Next Year5.89%
Revenue Next 2Y12.92%
Revenue Next 3Y11.09%
Revenue Next 5YN/A
EBIT growth 1Y0.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.4%
EBIT Next 3Y54%
EBIT Next 5YN/A
FCF growth 1Y412.1%
FCF growth 3YN/A
FCF growth 5Y24.61%
OCF growth 1Y522.7%
OCF growth 3YN/A
OCF growth 5Y11.89%